ST
ARNA

Spot Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Spot Trading’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,220
Closed -$23K – 4169
2015
Q4 		$23K Hold
1,220
– – ﹤0.01% 3210
2015
Q3 		$23K Hold
1,220
– – ﹤0.01% 3483
2015
Q2 		$57K Hold
1,220
– – ﹤0.01% 3254
2015
Q1 		$53K Sell
1,220
-9,230
-88% -$429K ﹤0.01% 3298
2014
Q4 		$363K Sell
10,450
-780
-7% -$31.7K ﹤0.01% 2566
2014
Q3 		$471K Sell
11,230
-150
-1% -$6.7K ﹤0.01% 2605
2014
Q2 		$667K Buy
11,380
+1,730
+18% +$109K ﹤0.01% 2459
2014
Q1 		$608K Sell
9,650
-1,460
-13% -$96.9K ﹤0.01% 2391
2013
Q4 		$650K Buy
11,110
+5,510
+98% +$288K ﹤0.01% 2283
2013
Q3 		$295K Buy
5,600
+4,380
+359% +$294K ﹤0.01% 2765
2013
Q2 		$94K Buy
+1,220
New +$99.6K ﹤0.01% 3464

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Spot Trading's ARNA Position: Q1 2016 in Review

Spot Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2016, closing a stake of 1,105 shares — an estimated $21K sold.

Spot Trading first reported a position in ARNA in Q3 2013 and held it in 8 quarters. The position peaked at $258K in Q4 2014. 111 funds tracked by Wall St. Rank hold ARNA as of Q1 2016.

  • Spot Trading reported no remaining Arena Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Spot Trading sold 1,105 Arena Pharmaceuticals Inc shares in Q1 2016, an estimated $21K.
  • Spot Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 8 quarters.
  • Spot Trading's Arena Pharmaceuticals Inc position peaked at $258K in Q4 2014.
  • 111 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2016.

Based on Spot Trading's 13F filing for Q1 2016, filed 10 May 2016.